combination quinidine-mexiletine therapy suppressed 80 % of ventricular premature complexes in 13 of 14 patients and suppressed 100 % of episodes of ventricular tachycardia in 6 of 8 patients ( mean quinidine dose 200 +/- 70 mg ; mean mexiletine dose 146 +/- 24 mg every 8 h ) .
C0025887
mexiletine
C0151636
ventricular premature complexes